Diabetes cataract study pulled before starting
NCT ID NCT04977427
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study was designed to compare a tiny steroid insert (Dextenza) placed in the tear duct against standard steroid eye drops (prednisolone) after cataract surgery in people with diabetes. The goal was to see which better controls eye inflammation and swelling. However, the study was withdrawn before enrolling any participants, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CATARACT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple stress ball or favorite tune replace anxiety meds during eye surgery?
- FitBit coaching may help amputees walk more after surgery
- Can a bangkok community eye check reveal hidden glaucoma risks?
- Can AI catch the leading cause of blindness before It's too late?
- Can trifocal lens implants keep night driving safe and clear?
- Which cataract tool works better? a Head-to-Head test in the same eyes